Literature DB >> 28454314

Synchronous and bilateral oncocytic carcinoma of the breast: A case report and review of the literature.

Hiroko Itagaki1,2, Tomoko Yamamoto1, Atsuko Hiroi1, Kunio Kawanishi1, Eiichiro Noguchi3, Tetsuya Ohchi3, Takako Kamio3, Shingo Kameoka3, Hideaki Oda2, Yoji Nagashima1.   

Abstract

Synchronous bilateral breast cancer is rare, and oncocytic carcinoma is an even rarer breast cancer histological subtype. In general, oncocytic tumors are defined as neoplasms with eosinophilic granular cytoplasm and have been reported in various organs. Oncocytic carcinoma of the breast was first documented by Gădăleanu and Craciun in 1987, and 48 cases have since been reported. The present study reports a case of synchronous bilateral breast oncocytic carcinoma. The patient was a 78-year-old woman. Although she exhibited no symptoms, chest computed tomography revealed three multinodular breast tumors: Two in the right breast and one in the left. Core needle biopsy was performed on the three tumors, and the patient was diagnosed with invasive ductal carcinoma with potential apocrine carcinoma. A bilateral modified radical mastectomy was performed. Surgical specimens of the three tumors revealed cord- or nest-forming tumor cells with eosinophilic granular cytoplasm. Immunohistochemically, the tumor cells were markedly positive for mitochondria. Electron microscopy of the tumor samples additionally revealed numerous mitochondria filling the cytoplasm. Based on these findings, the tumors were diagnosed as oncocytic carcinoma. The pathogenesis of oncocytic carcinoma remains to be fully elucidated; thus, additional clinicopathological studies are required.

Entities:  

Keywords:  bilateral; breast; mitochondria; oncocytic carcinoma; synchronous

Year:  2017        PMID: 28454314      PMCID: PMC5403532          DOI: 10.3892/ol.2017.5610

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  27 in total

1.  [Oncocytes and hyaline inclusions in the human breast].

Authors:  H Hamperl
Journal:  Virchows Arch B Cell Pathol       Date:  1972

2.  Electron microscopic study of apocrine secretion.

Authors:  K Hashimoto; B G Gross; W F Lever
Journal:  J Invest Dermatol       Date:  1966-04       Impact factor: 8.551

3.  American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer.

Authors:  Antonio C Wolff; M Elizabeth H Hammond; Jared N Schwartz; Karen L Hagerty; D Craig Allred; Richard J Cote; Mitchell Dowsett; Patrick L Fitzgibbons; Wedad M Hanna; Amy Langer; Lisa M McShane; Soonmyung Paik; Mark D Pegram; Edith A Perez; Michael F Press; Anthony Rhodes; Catharine Sturgeon; Sheila E Taube; Raymond Tubbs; Gail H Vance; Marc van de Vijver; Thomas M Wheeler; Daniel F Hayes
Journal:  J Clin Oncol       Date:  2006-12-11       Impact factor: 44.544

4.  Primary acinic cell carcinoma of the breast.

Authors:  J D Coyne; P A Dervan
Journal:  J Clin Pathol       Date:  2002-07       Impact factor: 3.411

5.  Malignant oncocytoma of the breast.

Authors:  V Gădăleanu; C Craciun
Journal:  Zentralbl Allg Pathol       Date:  1987

6.  Transcriptional profiling reveals coordinated up-regulation of oxidative metabolism genes in thyroid oncocytic tumors.

Authors:  Olivier Baris; Frédérique Savagner; Valéry Nasser; Béatrice Loriod; Samuel Granjeaud; Serge Guyetant; Brigitte Franc; Patrice Rodien; Vincent Rohmer; François Bertucci; Daniel Birnbaum; Yves Malthièry; Pascal Reynier; Rémi Houlgatte
Journal:  J Clin Endocrinol Metab       Date:  2004-02       Impact factor: 5.958

Review 7.  Oncocytic tumours.

Authors:  G Tallini
Journal:  Virchows Arch       Date:  1998-07       Impact factor: 4.064

8.  Bilateral carcinoma of the breast. Epidemiology and histopathology.

Authors:  H O Adami; J Hansen; B Jung; A Lindgren; A Rimsten
Journal:  Acta Radiol Oncol       Date:  1981

9.  A rare case of primary hyperparathyroidism associated with primary aldosteronism, Hürthle cell thyroid cancer and meningioma.

Authors:  You Lim Kim; Young Woo Jang; Jin Taek Kim; Su Ah Sung; Tae Seok Lee; Won Mi Lee; Hyo Jeong Kim
Journal:  J Korean Med Sci       Date:  2012-04-25       Impact factor: 2.153

10.  Genomic profiling of mitochondrion-rich breast carcinoma: chromosomal changes may be relevant for mitochondria accumulation and tumour biology.

Authors:  Felipe C Geyer; Dario de Biase; Maryou B K Lambros; Moira Ragazzi; Maria A Lopez-Garcia; Rachael Natrajan; Alan Mackay; Ivana Kurelac; Giuseppe Gasparre; Alan Ashworth; Vincenzo Eusebi; Jorge S Reis-Filho; Giovanni Tallini
Journal:  Breast Cancer Res Treat       Date:  2011-04-21       Impact factor: 4.872

View more
  1 in total

Review 1.  Rare Breast Cancer Subtypes.

Authors:  Sarah Jenkins; Megan E Kachur; Kamil Rechache; Justin M Wells; Stanley Lipkowitz
Journal:  Curr Oncol Rep       Date:  2021-03-23       Impact factor: 5.075

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.